A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa.

Trial Profile

A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 May 2017

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors IMPAX Laboratories
  • Most Recent Events

    • 25 Apr 2015 Results of pooled analysis of 7 phase II and III studies presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 13 Jul 2011 Results published in the Movement Disorders.
    • 14 Apr 2010 Results presented at the 62nd Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top